Jpo grants acurx pharmaceuticals patent in japan for dna polymerase iiic inhibitors

Staten island, n.y. , feb. 19, 2025 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that a new patent has been granted by the japanese patent office (jpo) in january 2025.
DNA Ratings Summary
DNA Quant Ranking